Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 23277 [2015-09647]

Download as PDF Federal Register / Vol. 80, No. 80 / Monday, April 27, 2015 / Notices 23277 DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Centers for Medicare & Medicaid Services Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Rmajette on DSK2VPTVN1PROD with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Special Interest Projects (SIP) 15–007, HPV Vaccine Impact among Men who have Sex with Men (MSM), and, SIP 15– 009, Serosorting and Other Seroadaptive Behaviors among Men who have Sex with Men (MSM) in the US-designing a Brief Survey Tool for Use in Clinical Practice. Time and Date: 10:00 a.m.–6:00 p.m., May 18, 2015 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘HPV Vaccine Impact among Men who have Sex with Men (MSM), SIP 15–007, and, Serosorting and Other Seroadaptive Behaviors among Men who have Sex with Men (MSM) in the US-designing a Brief Survey Tool for Use in Clinical Practice, SIP 15–009.’’ Contact Person for More Information: Brenda Colley Gilbert, Ph.D., M.S.P.H., Director, Extramural Research Program Operations and Services, CDC, 4770 Buford Highway NE., Mailstop F–80, Atlanta, Georgia 30341, Telephone: (770) 488–6295, BJC4@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Special Interest Projects (SIP) 15–002, Economic Impact of Clinical Trials among Children Diagnosed with Cancer, and, SIP 15–005, Economic Costs of Quality Assurance in Lung Cancer Screening Programs. Time and Date: 11:00 a.m.–6:00 p.m., May 19, 2015. Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Economic Impact of Clinical Trials among Children Diagnosed with Cancer, SIP 15–002, and, Economic Costs of Quality Assurance in Lung Cancer Screening Programs, SIP 15–005.’’ Contact Person for More Information: Brenda Colley Gilbert, Ph.D., M.S.P.H., Director, Extramural Research Program Operations and Services, CDC, 4770 Buford Highway NE., Mailstop F–80, Atlanta, Georgia 30341, Telephone: (770) 488–6295, BJC4@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–09647 Filed 4–24–15; 8:45 am] [FR Doc. 2015–09645 Filed 4–24–15; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P VerDate Sep<11>2014 14:41 Apr 24, 2015 Jkt 235001 PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 [CMS–7036–N2] Health Insurance Marketplace, Medicare, Medicaid, and Children’s Health Insurance Programs; Additional Request for Nominations for the Advisory Panel on Outreach and Education (APOE) Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice. AGENCY: This notice requests nominations for individuals to serve on the Advisory Panel on Outreach and Education (APOE). DATES: Nominations will be considered if we receive them at the appropriate address, provided in the ‘‘ADDRESSES’’ section of this notice, no later than 5 p.m., Eastern Daylight Time (e.d.t.) on May 18, 2015. ADDRESSES: Mail or deliver nominations to the following address: Abigail Huffman, Designated Federal Official, Office of Communications, CMS, 7500 Security Boulevard, Mail Stop S1–05– 06, Baltimore, MD 21244–1850 or email nominations to Abigail.Huffman1@ cms.hhs.gov. SUMMARY: FOR FURTHER INFORMATION CONTACT: Abigail Huffman, Designated Federal Official, Office of Communications, CMS, 7500 Security Boulevard, Mail Stop S1–05–06, Baltimore, MD 21244, 410–786–0897, email, Abigail.Huffman1@cms.hhs.gov or visit the Web site at https://www.cms.gov/ Regulations-and-Guidance/Guidance/ FACA/APOE.html. Press inquiries are handled through the CMS Press Office at (202) 690–6145. SUPPLEMENTARY INFORMATION: I. Background The Advisory Panel on Medicare Education (the predecessor to the APOE) was created in 1999 to advise and make recommendations to the Secretary of the U.S. Department of Health and Human Services (HHS), and the Administrator of the Centers for Medicare & Medicaid Services (CMS) on the effective implementation of national Medicare education programs, including with respect to the Medicare + Choice (M + C) program added by the Balanced Budget Act of 1997 (Pub. L. 105–33). The Medicare Modernization Act of 2003 (MMA) (Pub. L. 108–173) expanded the existing health plan options and benefits available under the E:\FR\FM\27APN1.SGM 27APN1

Agencies

[Federal Register Volume 80, Number 80 (Monday, April 27, 2015)]
[Notices]
[Page 23277]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-09647]



[[Page 23277]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Special Interest Projects (SIP) 15-007, HPV 
Vaccine Impact among Men who have Sex with Men (MSM), and, SIP 15-009, 
Serosorting and Other Seroadaptive Behaviors among Men who have Sex 
with Men (MSM) in the US-designing a Brief Survey Tool for Use in 
Clinical Practice.
    Time and Date: 10:00 a.m.-6:00 p.m., May 18, 2015 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``HPV Vaccine Impact among Men who have Sex with Men (MSM), SIP 15-
007, and, Serosorting and Other Seroadaptive Behaviors among Men who 
have Sex with Men (MSM) in the US-designing a Brief Survey Tool for Use 
in Clinical Practice, SIP 15-009.''
    Contact Person for More Information: Brenda Colley Gilbert, Ph.D., 
M.S.P.H., Director, Extramural Research Program Operations and 
Services, CDC, 4770 Buford Highway NE., Mailstop F-80, Atlanta, Georgia 
30341, Telephone: (770) 488-6295, BJC4@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2015-09647 Filed 4-24-15; 8:45 am]
 BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.